FRONTEO, Inc.
2158Growth MarketServices
2nd Quarter of FY2027/3Earnings Call
FRONTEO, Inc. targets 25+ AI drug discovery orders, at least one out-licensing deal and its first US project this fiscal year, with a 2H-weighted plan aimed at a full-year return to profitability
November 16, 2026 at 23:00 GMT+9







